Retired Ernst & Young Partner
Jerry Damerow served as Associate Director of the medical technology accelerator, UAMS BioVentures; as a Managing Partner for Ernst & Young operations in San Juan, Puerto Rico, and Southeast Asia; and as a management consultant for early stage businesses. Mr. Damerow is currently CFO of InterveXion Therapeutics, LLC a drug development company. Mr. Damerow’s civic and professional involvement includes serving as Board Member & Past Chair, CareLink; Council Member and Past Chair, Deans Science Council, Donaghey College of Science, Technology, Engineering, and Mathematics, University of Arkansas Little Rock; Chairman Emeritus, Hisco Inc.
Click on the tabs below to sort by board.